Personalised mRNA melanoma vaccine expected to secure approval next year
A late stage trial shows a bespoke mRNA vaccine combined with standard therapy significantly reduced melanoma recurrence or death, with regulatory approvals anticipated in 2027.
FTMQ Science, written by our newsroom0 views
A personalised mRNA vaccine designed to treat melanoma, the most lethal form of skin cancer, is anticipated to gain regulatory approval in the United States, Europe, and the United Kingdom next year. New Scientist reported that the bespoke treatment is tailored to target genetic mutations specific to an individual patient's tumor. [1]
In a late stage clinical trial, the vaccine was administered alongside standard treatment. New Scientist reported that this combination significantly reduced the risk of cancer recurrence or death over a two year follow up period. [1]
The therapy works by stimulating immune responses against unique cancer mutations. Alan Melcher stated that regulatory approval could happen quickly and that next year sounds reasonable, according to New Scientist. [1]
Melanoma targeted by the vaccine represents the deadliest variant of skin cancer. Pharmaceutical developments in this sector include work by multinational healthcare companies such as Merck and Co, which operates as Merck Sharp and Dohme outside the United States and Canada. [1][2]
In short
- A personalised mRNA melanoma vaccine is expected to be approved in the US, Europe, and the UK next year.
- The bespoke vaccine targets genetic mutations unique to an individual patient's cancer.
- When combined with standard treatment, the vaccine reduced melanoma recurrence or death over two years in a late stage trial.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Personalised cancer vaccine expected to be approved next yearNew Scientist, 11h ago (the report this story comes from)
Background
- [2]Merck & Co. on Wikipedia
Our newsroom writes these reports with the help of software, from the 2 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Science
Earlier reports of ours on the same people and subjects.
- Lactation drug cabergoline linked to reduced breast cancer risk after childbirthNew Research, 7d ago
- Younger colorectal cancer patients face frequent late stage diagnosesNew Research, 17d ago
- Black Death caused collapse in plant diversity across Europe, study showsTop Stories, 5d ago
More in Top Stories
- Sugar intake during antibiotic treatment harms gut bacteria diversity2h ago
- Actor Christina Applegate reveals misdiagnosis of multiple sclerosis after five years2h ago
- Artemis II commander recalls moments of fear during lunar mission1d ago
- Oak Ridge National Laboratory tests artificial intelligence to accelerate scientific research1d ago
- Rare silver coin depicting Olaf Haraldsson found in Norwegian Viking hoard2d ago
- James Webb Telescope Detects Concentration of Heavy Metals Near Central Black Hole2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.
Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.